Table 4.
Comparison of CT scan findings and respiratory signs and symptoms, and GI symptoms in COVID-19 patients of different symptom categories
| Variable | GIA (n = 92) | RA (n = 184) | GIR (n = 151) | P-value* |
|---|---|---|---|---|
| N (%) | N (%) | N (%) | ||
| Respiratory signs and symptoms | ||||
| Cough | 177 (96.2) | 136 (90.1) | 0.024 | |
| Shortness of breath | 11 (6.0) | 81 (53.6) | < 0.001 | |
| Intercostal retraction | 46 (25.0) | 0 (0) | < 0.001 | |
| Sore throat | 16 (8.7) | 12 (7.9) | 0.805 | |
| Rhinorrhea | 1 (0.5) | 6 (4.0) | 0.029† | |
| Chest pain | 11 (6.0) | 16 (10.6) | 0.122 | |
| Sputum production | 19 (10.3) | 26 (17.2) | 0.027 | |
| Bloody sputum/hemoptysis | 3 (1.6) | 4 (2.6) | 0.493† | |
| GI symptoms | ||||
| Abdominal pain | 27 (29.3) | 23 (15.2) | 0.008 | |
| Nausea and/or vomiting | 64 (69.6) | 96 (63.6) | 0.340 | |
| Diarrhea | 33 (35.9) | 57 (37.7) | 0.769 | |
| CT scan findings | ||||
| Local patchy shadowing | 1 (1.3) | 2 (1.4) | 1.000† | |
| Interstitial abnormalities | 2 (2.5) | 1 (0.7) | 0.296† | |
| Peripheral opacities | 1 (1.3) | 6 (4.3) | 0.426† | |
| Linear opacities | 2 (2.5) | 2 (1.4) | 0.621† | |
| Discrete nodule | 1 (1.3) | 4 (2.9) | 0.656† | |
| Unilateral involvement | 0 (0) | 3 (2.1) | 0.555† | |
| Bilateral involvement | 3 (3.8) | 13 (9.3) | 0.134 | |
RA respiratory alone, GIA gastrointestinal alone, GIR gastrointestinal and respiratory, WGIR without gastrointestinal or respiratory, N number, CT computed tomography, GI gastrointestinal
*Analyzed by Chi-squared test
†Analyzed by Fisher’s exact test